» Articles » PMID: 32283497

Telemedicine for Diabetes Care in India During COVID19 Pandemic and National Lockdown Period: Guidelines for Physicians

Overview
Specialty Endocrinology
Date 2020 Apr 14
PMID 32283497
Citations 105
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aims: In view of restrictions on mobility of patients because of COVID-19 pandemic, face-to-face consultations are difficult. We sought to study the feasibility of telemedicine in this scenario.

Methods: PubMed and Google Scholar search engines were searched using the key terms 'telemedicine', 'diabetes', 'COVID-19 up to 31 March 2020. In addition, existing guidelines including those by Ministry of Health and Family Welfare (MOHFW), Government of India, were accessed.

Results: We discuss evidence and general guidelines regarding role of telemedicine in patients with diabetes along with its utility and limitations.

Conclusions: Telemedicine is a useful tool for managing patients of diabetes during this lockdown period. However, there is limited data and further research is required.

Citing Articles

Impact of Virtual Clinics on Diabetes Distress and HbA1c Levels Among Patients with Diabetes Mellitus in Saudi Arabia.

Almarzooq M, Almarzoug H, Alhassan M, Alrashed M, Alnajjar J, Albejais N Medicina (Kaunas). 2025; 61(2).

PMID: 40005351 PMC: 11857536. DOI: 10.3390/medicina61020234.


Challenges of using telemedicine for patients with diabetes during the COVID-19 pandemic: A scoping review.

Mirasghari F, Ayatollahi H, Velayati F, Abasi A J Clin Transl Endocrinol. 2024; 37:100361.

PMID: 39114582 PMC: 11304064. DOI: 10.1016/j.jcte.2024.100361.


Tackling syndemics by integrating infectious and noncommunicable diseases in health systems of low- and middle-income countries: A narrative systematic review.

Jackson-Morris A, Masyuko S, Morrell L, Kataria I, Kocher E, Nugent R PLOS Glob Public Health. 2024; 4(5):e0003114.

PMID: 38753811 PMC: 11098501. DOI: 10.1371/journal.pgph.0003114.


A Topical Review on Enabling Technologies for the Internet of Medical Things: Sensors, Devices, Platforms, and Applications.

Arefin M, Rahman M, Hasan M, Mahmud M Micromachines (Basel). 2024; 15(4).

PMID: 38675290 PMC: 11051832. DOI: 10.3390/mi15040479.


Decentralisation of healthcare system due to COVID-19 and its impact on hospital based laboratories - Pandemic panic patients' reflection?.

Jayamani J, Thangaraju P, Thangaraju E, Venkatesan S J Responsib Technol. 2024; 1:100003.

PMID: 38620674 PMC: 7834502. DOI: 10.1016/j.jrt.2020.100003.


References
1.
Zhai Y, Zhu W, Cai Y, Sun D, Zhao J . Clinical- and cost-effectiveness of telemedicine in type 2 diabetes mellitus: a systematic review and meta-analysis. Medicine (Baltimore). 2014; 93(28):e312. PMC: 4603080. DOI: 10.1097/MD.0000000000000312. View

2.
Gupta R, Ghosh A, Singh A, Misra A . Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes Metab Syndr. 2020; 14(3):211-212. PMC: 7102582. DOI: 10.1016/j.dsx.2020.03.002. View

3.
Onder G, Rezza G, Brusaferro S . Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA. 2020; 323(18):1775-1776. DOI: 10.1001/jama.2020.4683. View

4.
Timpel P, Oswald S, Schwarz P, Harst L . Mapping the Evidence on the Effectiveness of Telemedicine Interventions in Diabetes, Dyslipidemia, and Hypertension: An Umbrella Review of Systematic Reviews and Meta-Analyses. J Med Internet Res. 2020; 22(3):e16791. PMC: 7113804. DOI: 10.2196/16791. View

5.
Gopalan H, Haque I, Ahmad S, Gaur A, Misra A . "Diabetes care at doorsteps": A customised mobile van for the prevention, screening, detection and management of diabetes in the urban underprivileged populations of Delhi. Diabetes Metab Syndr. 2019; 13(6):3105-3112. DOI: 10.1016/j.dsx.2019.11.008. View